首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Pharmacokinetic analysis of mannose receptor-mediated hepatic targeting of proteins: capacity-limited hepatic uptake and saturable binding in plasma
【24h】

Pharmacokinetic analysis of mannose receptor-mediated hepatic targeting of proteins: capacity-limited hepatic uptake and saturable binding in plasma

机译:甘露糖受体介导的肝靶向蛋白质的药代动力学分析:容量受限的肝吸收和血浆中的饱和结合

获取原文

摘要

Carbohydrate receptor-mediated endocytosis is a highly cell-specific event and can be applied to in vivo targeted delivery of low molecular-weight drugs, biologically active proteins and DNAs. The asialoglycoprotein (ASGP) receptor expressed only in hepatocytes is one of the most widely utilized mechanisms to deliver biologically active compounds to the cells. We have previously examined the pharmacokinetic aspects of the ASGP receptor-mediated hepatic targeting of galactosylated macromolecules in whole animals and in situ perfused liver. Through these studies it has been revealed that the hepatic uptake is capacity-limited, and the uptake clearance is influenced by the degree of galactosylation.
机译:碳水化合物受体介导的内吞作用是高度细胞特异性事件,可用于体内靶向递送低分子量药物,生物活性蛋白质和DNA。仅在肝细胞中表达的去唾液酸糖蛋白(ASGP)受体是将生物活性化合物传递至细胞的最广泛使用的机制之一。我们之前已经检查了ASGP受体介导的半乳糖基化大分子在整只动物和原位灌注肝脏中对肝脏的药代动力学方面。通过这些研究表明,肝脏的摄取受到容量的限制,摄取清除率受半乳糖基化程度的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号